Mycobiologics
Aberdeen
About Mycobiologics
mycoBiologics develops novel biologics for systemic fungal infections using its proprietary FungoBiologic platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $113.3K
- Last round: Grant (Dec 2025)
- Website: mycobiologics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/mycobiologics-146172 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.